Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 1.5% in the afternoon session after it announced a strategic partnership with SPT Labtech, a laboratory automation company, to provide ...

View 10x Genomics Inc Class A TXG stock quote prices, financial information, real-time forecasts, and company news from CNN.

On March 31, 2026, William Blair upgraded 10x Genomics from “Market Perform” to “Outperform,” highlighting its best-in-class genomics platforms and exposure to growing demand for large-scale ...

10x Genomics (TXG) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

William Blair upgraded 10x Genomics Inc. TXG stock, citing it as the best-in-class technology and is well-positioned to ...

The market misinterprets past COVID-era revenue growth for 10x Genomics and fails to integrate current sector growth. Read why TXG stock is a Buy.

Wall Street expects a year-over-year increase in earnings on lower revenues when 10x Genomics (TXG) reports results for the quarter ended September 2025. While this widely-known consensus outlook is ...

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $27.5 million in its third quarter. The Pleasanton, California-based company said it had a ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Thursday, 2026-02-12. Here's what investors need to know before the announcement. Analysts estimate that 10x Genomics ...